Delivery Order SPE2DR25D3005-SPE2DR26FP8EF
- Not listed
- The Defense Logistics Agency awarded a $2,103.45 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on December 19, 2025, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,086.86 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on December 17, 2025, with completion scheduled for December 18, 2025. This competitively awarded, firm fixed-price delivery order was performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.73 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 13, 2025, with completion scheduled for August 14, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, procured through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,244.00 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on November 20, 2025, with an ultimate completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,144.01 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency awarded a $1,357.95 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 MCG vaginal insert (18-pack) on December 17, 2025, with completion targeted for December 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency has awarded a delivery order valued at $1,822.14 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count package). This firm fixed-price, non-competitive delivery order was issued on November 25, 2025, with an ultimate completion date of November 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,013.49 to AmerisourceBergen Drug Corp for Yuvafem 10 micrograms vaginal inserts (8-count package) on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $1,073.04 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on May 20, 2025, with completion scheduled for May 21, 2025. This contract was awarded on a firm fixed-price basis without set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. This...
- The Defense Logistics Agency awarded a $35,938.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8EFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,702.11 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8 count) on December 22, 2025, with completion scheduled for December 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical procurement needs for military and veteran healthcare systems through its extensive federal contract portfolio. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for the hormone replacement therapy product falls within the company's demonstrated capability to provide specialized medications across multiple therapeutic domains and reflects the ongoing pharmaceutical supply requirements of the federal government's defense and military healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/21/25 |